Abstract:Technology and techniques for minimally invasive endovascular revascularization in patients with peripheral artery disease have rapidly evolved during the last decade, and there is a growing body of experience in the treatment of even complex cases. Endovascular approaches now represent the initial strategy for managing the majority of these mostly polymorbid and therefore high-risk patients. Different technologies, especially stent implantation to resolve the problems of residual stenosis, elastic recoil, and flowlimiting arterial dissection, enable optimization of the primary technical result. However, restenosis has remained, until now, the major drawback of all endovascular techniques. The two primary phenomena that contribute to restenosis after successful angioplasty are chronic vessel constriction (negative remodeling) and neointimal hyperplasia by means of cell proliferation. While stents can reduce acute recoil and the constricting effect of vascular remodeling, they also enhance neointima proliferation within the stent, leading to in-stent stenosis (ISS). Migration of smooth muscle cells through the mesh of the stent and lumen-narrowing proliferation are the hallmarks of ISS. Owing to this, the patency rates of femoropopliteal stenting with the currently available bare nitinol stents are still suboptimal. Increasing knowledge about the pathophysiology of the process leading to restenosis has formerly given the rationale to investigate the potential role of radiation in the prevention of restenosis. Nearly two decades ago, vascular brachytherapy (BT) emerged as a promising, novel technology, with the potential to reduce the rates of restenosis. Different techniques for application of peripheral vascular BT have been studied. Possible technical approaches included external beam radiation with gamma-emitting sources or endovascular BT with radioactive balloons, radioactive stents, high-dose remote gamma radiation, or beta-emitting sources. In the coronary field, vascular BT using beta and gamma irradiation revolutionized the treatment of ISS at that time. In the femoropopliteal segment, centered and noncentered devices with different doses have been applied. Unfortunately, the pivotal trial of BT for the femoral and popliteal arteries using a centering balloon (Paris) catheter with a high dose rate remote afterloader did not show any superior efficacy of radiation over angioplasty alone. To the contrary, several single and multi-institution randomized trials in Europe have demonstrated beneficial short and midterm effects of BT in the femoropopliteal segment in de novo lesions and, especially, in recurrences. BT in peripheral vessels has almost exclusively been based on studies using iridium 192 and high-dose-rate remote afterloader devices to deliver gamma irradiation. Endovascular gamma BT has been applied in dosages of 12, 14, and 18 Gy at a depth of 2 mm into the arterial wall. The cumulative 12month patency in the Vienna-3 trial, using a dose of 18 Gy at 2 mm, seemed superior to the patency achieved in the Vienna-2 trial

Computational Drug Repositioning Based on Multi-Similarities Bilinear Matrix Factorization.

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

A weighted bilinear neural collaborative filtering approach for drug repositioning

EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy.

The Neural Metric Factorization for Computational Drug Repositioning

In silico drug repositioning based on drug-miRNA associations

Drug repositioning based on the target microRNAs using bilateral-inductive matrix completion

Predicting drug-target interactions using matrix factorization with self-paced learning and dual similarity information

Collaborative Matrix Factorization with Multiple Similarities for Predicting Drug-Target Interactions

DIVERSE: Bayesian Data IntegratiVE learning for precise drug ResponSE prediction

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

Mixed lymphocyte tumour cell whole blood microcultures in large bowel carcinoma patients.

A computational drug repositioning model based on hybrid similarity side information powered graph neural network

Computational Approaches for Predicting Drug-Disease Associations: A Comprehensive Review

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

Resuscitation of Endovascular Brachytherapy Owing to Improved Logistics